In this study, we have shown that moderate to high levels of EGFR phosphorylation (Y1086) were observed in 67 out of 89 (75.3%) primary breast tumours and was associated with invasive breast tumours (P<0.05) (Table 1). This evidence concerns the gene EGFR and breast neoplasm.